Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jeffrey Slott (NPI 1366453128)

Field	Value
Entity Type	Individual
Organization	Jeffrey Slott
Address	400 Westhampton Sta
City	Richmond
State	VA
ZIP	23226
Taxonomy	Ophthalmology Physician
NPI Enumerated	August 10, 2006

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This provider is effectively single-payer in scope: Total Medicare revenue is $2.6M while Total Medicaid revenue is none (no Medicaid billing on file), so all reported public-payer billing in our dataset is concentrated in Medicare. That concentration means payer-negotiation exposure and patient-mix signals will be driven entirely by Medicare reimbursement and utilization trends rather than by dual payer dynamics.

Revenue is highly concentrated in a very small set of services: the precomputed top 3 Medicare codes by revenue account for 77.6% of this provider's total Medicare revenue. The two drug/injectable codes J0178 and J2777 are the single largest revenue drivers, with J0178 reported as $953.6K revenue (36.9%) and J2777 reported as $920.5K revenue (35.6%), and 99214 contributing an additional $131.9K (5.1%).

The code mix and unit-level detail point to a retina-focused ophthalmology practice built around pharmacologic intravitreal therapy and high office visit intensity. High-revenue drug codes J0178 (Injection, aflibercept) and J2777 (Injection, faricimab-svoa) and procedural codes such as 67028 (intravitreal injection) appear alongside frequent E/M codes, indicating the clinic provides repeated in‑office injections plus follow-up management and monitoring.

Provider-level E/M volume is an outlier versus national peers, suggesting a large established patient panel or higher visit frequency: 99214 shows 1.4K claims, $92 avg paid/claim, $131.9K revenue and ranks #4139 of 479517 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). 99213 likewise reports 2.1K claims, $64 avg paid/claim, $131.8K revenue and ranks #784 of 457151 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code).

Imaging and procedural volumes underscore active diagnostic monitoring consistent with retina care: 92134 (retinal imaging) reports 3.3K claims, $31 avg paid/claim, $103.3K revenue and ranks #274 of 26868 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). The procedure 67028 (vitreous injection) appears with 1.4K claims, $96 avg paid/claim, $130.9K revenue and ranks #941 of 4255 providers nationally (78th percentile; typical, unremarkable volume for this code).

Competitive standing for the core injectable therapies is mixed: J2777 ranks #267 of 2039 providers nationally (87th percentile; typical, unremarkable volume for this code) and J0178 ranks #905 of 3204 providers nationally (72th percentile; typical, unremarkable volume for this code), indicating solid but not dominant national position on these drug administrations. In contrast, the provider is a distinct high-volume outlier for office visit and retinal imaging codes, which suggests a practice that is regionally busy and focused on repeat care rather than claiming dominance specifically on a single drug product.

Operational and revenue risk is concentrated in high-cost, high-volume injectable medications: the practice derives most of its Medicare revenue from J0178 and J2777, and changes in utilization patterns, drug pricing, or reimbursement policy for these specific J-codes would disproportionately affect overall revenue. Given the lack of Medicaid billing on file, any shifts in Medicare policy would not be offset by a Medicaid revenue stream in the dataset.

Tenure data indicate an established practice footprint: NPI enumerated (registered): 2006-08-10 (~20 years ago), which, combined with extreme national outlier status on several E/M and imaging codes, suggests long-term local patient panel development and sustained service-line specialization in retinal diagnosis and intravitreal therapy.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,390	$690	$953.6K
J2777	Injection, faricimab‑svoa, 0.1 mg	31,740	$30	$920.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,430	$90	$131.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	2,060	$60	$131.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,360	$100	$130.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,330	$30	$103.3K
J2778	Injection, ranibizumab, 0.1 mg	530	$180	$95.6K
J3590	Unclassified biologics	30	$2,500	$69.9K
J0179	Injection, brolucizumab-dbll, 1 mg	100	$240	$24.4K
J9035	Injection, bevacizumab, 10 mg	150	$50	$7.5K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Jeffrey Slott — 3 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	39	80	1,400	$690	$1.1M
J2777	9	60	13,200	$30	$517.1K
J2778	21	40	560	$180	$171.5K
J3590	11	20	40	$2,290	$126K
67028	36	90	1,000	$90	$107.1K
J0179	3	10	230	$240	$54.7K
92014	773	870	170	$80	$32.8K
99214	119	12,890	140	$80	$21K
J9035	31	60	170	$50	$19.9K
67210	8	10	20	$370	$14.5K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jeffrey Slott, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Virginia Eye Institute Inc	VA	Ambulatory Surgical Clinic/Center	$4.8M	$696.2K
David Jacobs	VA	Ophthalmology Physician	$4M	$0
Byron Ladd	VA	Ophthalmology Physician	$3.8M	$0
Ryan Deasy	VA	Ophthalmology Physician	$3.3M	$0
Philip Cofoid	TX	Ophthalmology Physician	$510.3K	$0
Seth Krawitz	VA	Ophthalmology Physician	$484K	$0
Grover Robinson	VA	Ophthalmology Physician	$468.5K	$0
Robert Knape	VA	Ophthalmology Physician	$467.9K	$0
Francis Larosa	VA	Ophthalmology Physician	$432.1K	$0
Theodore Wu	VA	Ophthalmology Physician	$428.6K	$0

Nearby Providers

Other providers in the same ZIP code as Jeffrey Slott, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Home Care Delivered, Inc.	VA	Durable Medical Equipment & Medical Supplies	$0	$309.5M
Bon Secours St. Mary's Hospital Of Richmond LLC	VA	General Acute Care Hospital	$0	$83.1M
Cep America, LLC	VA	Emergency Medicine Physician	$0	$9.7M
Richmond Emergency Physicians, Inc.	VA	Specialist	$0	$7.9M
At Home Care Staffing-richmond	VA	Home Health Agency	$0	$5.6M
St. Mary's Ambulatory Surgery Center, LLC	VA	Ambulatory Surgical Clinic/Center	$1.6M	$0
Cataract And Refractive Surgery Center, LLC	VA	Ambulatory Surgical Clinic/Center	$1.1M	$461.6K
Darryn Appleton	VA	Interventional Cardiology Physician	$590.5K	$0
Jed Vanichkachorn	VA	Orthopaedic Surgery of the Spine Physician	$557.2K	$0
Christopher Thomas	VA	Cardiovascular Disease Physician	$528.7K	$0

Jeffrey Slott — Billing Profile & Reimbursement Data

Sign up for Jeffrey Slott — Billing Profile & Reimbursement Data policy alerts

Jeffrey Slott — Billing Profile & Reimbursement Data

Sign up for Jeffrey Slott — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References